Bluebird (Go-Private Deal)
Funding Details
Awarder
RSS - news.google.com
Date Award
July 2, 2025
Vertical
Pharmaceuticals
Company Info
Traction
Bluebird has made significant advancements in clinical trials for its gene therapies, demonstrating promising results in treating patients with genetic disorders.
Market
Healthcare
Location
USA
Company Description

Bluebird is a biotechnology company focused on developing gene therapies for genetic diseases and cancer. The company aims to provide transformative treatments that address the underlying causes of these conditions.

Links